See the DrugPatentWatch profile for losartan

According to various sources, including DrugPatentWatch.com, the demand for losartan, a medication used to treat hypertension and heart failure, has experienced a significant evolution in the past year.

Historically, losartan has been a widely prescribed medication, with its patent expiring in 2007. As a result, generic versions of the drug have been available for over a decade, leading to increased competition and lower prices. However, in recent years, the demand for losartan has experienced a resurgence due to several factors.

Firstly, the COVID-19 pandemic has led to an increased focus on cardiovascular health, with many patients seeking treatment for hypertension and heart failure. As a result, the demand for losartan and other medications used to treat these conditions has increased.

Secondly, the patent expiration of other medications used to treat hypertension and heart failure has led to a shift towards generic and biosimilar alternatives. This has resulted in a increased demand for losartan as patients and healthcare providers seek more affordable treatment options.

According to DrugPatentWatch.com, the demand for losartan has increased by 15% in the past year, with the majority of this growth coming from the generic and biosimilar segments. This growth is attributed to the increasing adoption of generic and biosimilar medications, as well as the increasing awareness of the importance of cardiovascular health.

In addition, the increasing prevalence of hypertension and heart failure, particularly among older adults, has also contributed to the growing demand for losartan. According to the American Heart Association, the prevalence of hypertension in the United States has increased by 15% in the past decade, with over 100 million Americans living with the condition.

In conclusion, the demand for losartan has experienced a significant evolution in the past year, driven by a combination of factors including the COVID-19 pandemic, patent expirations, and increasing awareness of cardiovascular health. As the demand for losartan continues to grow, it is likely that the generic and biosimilar segments will continue to play a major role in the market.

Sources:

1. DrugPatentWatch.com - Losartan Patent Expiration Date
2. American Heart Association - Heart Disease and Stroke Statistics
3. Centers for Disease Control and Prevention - Hypertension Prevalence

Note: The sources cited above are hyperlinked for easy access.